Leading genomic innovation beyond traditional boundaries
Our groundbreaking technology is designed to fill essential gaps in genomics research, diagnostics, therapeutics, and drug development.
Our innovative method identifies genomic data and modifications inaccessible with other commercial technologies.
Our distinctive platform does not require DNA amplification, labels, or library preparation.
Research & Technology
Using the power of machine learning we have:
-
Developed rapidly manufacturable metamaterial/plasmonic nanostructures with outstanding sensitivity for non-resonant SERS single nucleotide detection.
-
Demonstrated our detection of single nucleotides.
-
Integrated our structures into chips, where we control velocity with electric fields.
Armonica Tech., San Diego laboratories
Armonica’s Center on the University of New Mexico campus
Center for High Technology Materials (CHTM/UNM) Facilities
Center for Integrated Nanotechnologies (Sandia and Los Alamos National Laboratories)
UCSD Nano3 facility at the University of California-San Diego
In the Press
Problem
Current genomic analysis methods often miss critical epigenetic data and important genomic markers, leading to significant diagnostic gaps.
Detect of large structural variants, long range epigenetic mapping, and de novo genome assembly
Sequence ultra-long, native nucleic acid molecules at single base resolution
No labeling or amplification of target nucleic acid is required, and the sequence is read in real-time.